This inventor holds 2 USPTO granted patents. Top assignees: University of California, Leland Stanford Junior University. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024-2026
Title: Katelyn E Masiuk: Innovator in Lentiviral Vector Technology
Introduction
Katelyn E Masiuk is a prominent inventor based in Santa Monica, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of lentiviral vectors. Her innovative work has implications for gene therapy and immunology.
Latest Patents
Katelyn holds a patent for a "Self-inactivating lentiviral vector comprising a FOXP3 expression cassette." This patent describes various embodiments of lentiviral vectors that express FoxP3, utilizing endogenous gene elements to regulate the physiological gene expression of FoxP3. This technology has the potential to advance therapeutic strategies in treating autoimmune diseases.
Career Highlights
Throughout her career, Katelyn has worked with esteemed institutions such as the University of California and Leland Stanford Junior University. Her research has focused on the intersection of gene therapy and immunology, contributing to advancements in the understanding and treatment of various diseases.
Collaborations
Katelyn has collaborated with notable scientists in her field, including Donald B Kohn and Maria Grazia Roncarolo. These collaborations have enriched her research and expanded the impact of her innovations.
Conclusion
Katelyn E Masiuk is a trailblazer in the field of lentiviral vector technology, with a patent that showcases her innovative approach to gene therapy. Her work continues to influence the landscape of biotechnology and holds promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile